Enfuvirtide (CAS 159519-65-0) — formula C204H301N51O64, molecular weight 4492.
| CAS Number | 159519-65-0 |
|---|---|
| Molecular Formula | C204H301N51O64 |
| Molecular Weight | 4492 |
| LogP | -14.7 |
| Applications | Uses: Medication, Antiviral (systemic), Methods of Manufacturing: Preparation ... D.P. Bolognesi et al, WO 94 28920, eidem, US 5464933 (1994, 1995 both to Duke University), Formulations, Preparations: Parenteral: For injection: 108 mg Fuzeon (with sterile water for injection diluent), (Roche)., General Manufacturing Information: Whilte data specific to enfuvirtide were not located(SRC, 2005), the literature suggests that some pharmaceutically active compounds originating from human and veterinary therapy are not eliminated completely in municipal sewage treatment plants and are therefore discharged into receiving waters(1). Wastewater treatment processes often were not designed to remove them from the effluent(2). Selected organic waste compounds may be degrading to new and more persistent compounds that may be released instead of or in addition to the parent compound(2). Studies have indicated that several polar pharmaceutically active compounds can leach through subsoils into aquifers(1). |
Documented applications: Uses: Medication, Antiviral (systemic), Methods of Manufacturing: Preparation ... D.P. Bolognesi et al, WO 94 28920, eidem, US 5464933 (1994, 1995 both to Duke University), Formulations, Preparations: Parenteral: For injection: 108 mg Fuzeon (with sterile water for injection diluent), (Roche)., General Manufacturing Information: Whilte data specific to enfuvirtide were not located(SRC, 2005), the literature suggests that some pharmaceutically active compounds originating from human and veterinary therapy are not eliminated completely in municipal sewage treatment plants and are therefore discharged into receiving waters(1). Wastewater treatment processes often were not designed to remove them from the effluent(2). Selected organic waste compounds may be degrading to new and more persistent compounds that may be released instead of or in addition to the parent compound(2). Studies have indicated that several polar pharmaceutically active compounds can leach through subsoils into aquifers(1)..
Enfuvirtide is a chemical compound with CAS registry number 159519-65-0 and molecular formula C204H301N51O64 (molecular weight 4492).
CAS number: 159519-65-0
Its molecular formula C204H301N51O64 comprises 204 C, 301 H, 51 N, 64 O atoms.
Also known as: Enfuvirtide · 恩夫韦肽
The CAS registry number of Enfuvirtide is 159519-65-0.
Molecular formula C204H301N51O64, molecular weight 4492.
It is also registered under: Enfuvirtide, 恩夫韦肽.
Recorded applications: Uses: Medication, Antiviral (systemic), Methods of Manufacturing: Preparation ... D.P. Bolognesi et al, WO 94 28920, eidem, US 5464933 (1994, 1995 both to Duke University), Formulations, Preparations: Parenteral: For injection: 108 mg Fuzeon (with sterile water for injection diluent), (Roche)., General Manufacturing Information: Whilte data specific to enfuvirtide were not located(SRC, 2005), the literature suggests that some pharmaceutically active compounds originating from human and veterinary therapy are not eliminated completely in municipal sewage treatment plants and are therefore discharged into receiving waters(1). Wastewater treatment processes often were not designed to remove them from the effluent(2). Selected organic waste compounds may be degrading to new and more persistent compounds that may be released instead of or in addition to the parent compound(2). Studies have indicated that several polar pharmaceutically active compounds can leach through subsoils into aquifers(1)..
Independent reference data for Enfuvirtide (CAS 159519-65-0), compiled from public chemistry databases.
| CAS Registry Number | 159519-65-0 |
|---|---|
| PubChem CID | 16130199 |
| Molecular formula | C204H301N51O64 |
| UNII (FDA) | 19OWO1T3ZE |
| Molecular Weight | 4492 |
|---|---|
| XLogP3 | -14.7 |
| Hydrogen Bond Donor Count | 63 |
| Hydrogen Bond Acceptor Count | 67 |
| Rotatable Bond Count | 151 |
| Exact Mass | 4491.1933541 |
| Monoisotopic Mass | 4489.1866445 |
| Topological Polar Surface Area | 1900 |
| Heavy Atom Count | 319 |
| Hydrophobicity | -0.875 |
|---|
Enfuvirtide; Pentafuside; Fuzeon; DP178; DP-178; Enfuvirtida; CHEBI:608828; Fuzeon T-20; 19OWO1T3ZE; DTXSID20166672; peptide T20; T20, Peptide; enfuvirtidum; RefChem:55093; DTXCID8089163; J05AX07
| Reported hazard statements | H317 (100%) |
|---|
H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]
P261, P272, P280, P302+P352, P321, P333+P317, P362+P364, and P501 (click each P-code to see the statement)
Enfuvirtide · CAS 159519-65-0 · C204H301N51O64. UNII 19OWO1T3ZE. Hydrophobicity: -0.875.
Source: PubChem / Wikidata; the batch COA governs where values differ.
Supplier: Jinan Shenghe Chemical Co., Ltd.
中文页面: 恩夫韦肽